Company: BGLC
Filing Date: 2025-08-18
Form Type: 10-Q
Source: 0001477932-25-006023
Chunk: 23

Company: BioNexus Gene Lab Corp
Filing Date: 2025-08-18
Form: 10-Q
Item: Part I, Item 1
Chunk 23
---
 with a loss on lease termination recorded for $1,384.   As of   June 30,  December 31,   2025  2024 Supplemental Cash Flow Disclosures:       Cash paid for amounts included in the measurement of lease liabilities:      Lease payment – operating leases $(32,176) $(56,598)Operating lease liabilities obtained in exchange for operating lease assets  -   145,736          Other information:         Weighted average remaining lease term for operating lease (years)  3.92   4.42 Weighted average discount rate for operating lease  6.65%  6.65% (4) Lease expenses for the six month period ended June 30, 2025 and 2024 were $33,932 and $25,296 respectively.

 18Table of Contents

BIONEXUS GENE LAB CORP. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 

FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND 2024 

(Currency expressed in United States Dollars (“US$”)) 

(Unaudited)

NOTE 6 - PROPERTY, PLANT AND EQUIPMENT  Property, plant and equipment consisted of the following:    As of   June 30,  December 31,   2025  2024        Air conditioner  $1,124  $1,124 Computer and software  5,880   5,880 Equipment  65,360   65,214 Furniture and fittings  98,883   98,883 Lab equipment  320,102   320,102 Land and buildings  1,506,969   1,506,969 Motor vehicle  161,148   161,148 Office equipment  41,108   37,604 Renovation  106,441   101,137 Signboard  806   806 Solar PV System  16,935   16,935 Machinery  211,898   190,341    2,536,654   2,506,143 (Less): Accumulated depreciation  (811,418)  (756,976)(Less): Accumulated impairment